Does chemotherapy affect your nerves?

 

 

Q: Does chemotherapy affect your nerves?

A: Chemotherapy and biologic therapy can affect the central nervous system as well as nerves in your fingers and toes (peripheral nervous system). Nerve cells may be irritated or damaged during chemotherapy or biologic therapy. This can produce everything from mild confusion or forgetfulness, lack of concentration, and dizziness to more serious behavior changes. Altering the amount of medication or treating other contributing factors (such as dehydration) usually improves these symptoms.

Other nervous system problems that may arise from chemotherapy include numbness or tingling in your hands and feet. If your hands and feet feel numb or tingly, let your doctor know right away. A medication change may be indicated because peripheral neuropathy can become a long-term condition if not addressed quickly.

Cancer therapy can also affect your “nerves” as it relates to your emotional response to treatment; in other words, you may find that you experience feelings of anxiety, jumpiness, and a general inability to relax. It’s important to be open with your health care team about these sorts of symptoms, too, so they can help you.

--Bernice Crook, RN, OCN

Some chemotherapy drugs are more likely to cause numbness from nerve damage.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health